Perinatal Protease Inhibitor Trials Expected To Resume By End Of Summer
Executive Summary
Three Phase I studies examining the treatment of HIV-positive pregnant women with protease inhibitors will resume enrollment in the next several weeks after information on premature births is added to the protocol.